QUARTERLY RESULTS
Zydus Lifesciences Ltd.
BSE
May 02
885.45
-2.25 ( -0.25%)
Volume
11464
Prev. Close
887.70
Open Price
890.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
May 02
885.60
-2.65 ( -0.30%)
Volume
803068
Prev. Close
888.25
Open Price
887.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE010B01027
|
Market Cap. ( ₹ in Cr. )
|
89112.08
|
P/BV
|
4.08
|
Book Value ( ₹ )
|
216.89
|
|
BSE Code
|
532321
|
52 Week High/Low ( ₹ )
|
1324/795
|
FV/ML
|
1/1
|
P/E(X)
|
23.09
|
|
NSE Code
|
ZYDUSLIFEEQ
|
Book Closure
|
26/07/2024
|
EPS ( ₹ )
|
38.36
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 2408.90 | 2512.30 | 4035.40 | 3172.60 | 2371.30 |
| Other Operating Income | 107.00 | 108.30 | 124.80 | 159.80 | 0.00 |
| Total Income From Operations | 2515.90 | 2620.60 | 4160.20 | 3332.40 | 2371.30 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 635.80 | 704.80 | 725.70 | 737.20 | 681.60 |
| Purchase of Traded Goods | 112.10 | 87.10 | 58.70 | 71.10 | 68.70 |
| Increase/Decrease in Stocks | 187.80 | -138.90 | -46.40 | -86.20 | 24.50 |
| Employees Cost | 425.00 | 436.50 | 424.40 | 405.10 | 373.00 |
| Depreciation | 131.60 | 133.70 | 130.60 | 130.60 | 127.70 |
| Other Expenses | 506.70 | 588.90 | 624.90 | 636.00 | 524.40 |
| Total Expenses | 1999.00 | 1812.10 | 1917.90 | 1893.80 | 1799.90 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 516.90 | 808.50 | 2242.30 | 1438.60 | 571.40 |
| Other Income | 77.50 | 326.70 | 106.60 | 361.10 | 106.80 |
| P/L Before Interest, Excpt. Items & Tax | 594.40 | 1135.20 | 2348.90 | 1799.70 | 678.20 |
| Interest | 97.20 | 95.90 | 115.40 | 106.20 | 103.90 |
| P/L Before Exceptional Items & Tax | 497.20 | 1039.30 | 2233.50 | 1693.50 | 574.30 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | -8.60 | 0.00 |
| P/L Before Tax | 497.20 | 1039.30 | 2233.50 | 1684.90 | 574.30 |
| Tax | 26.60 | 249.50 | 532.70 | 279.70 | 123.90 |
| P/L After Tax from Ordinary Activities | 470.60 | 789.80 | 1700.80 | 1405.20 | 450.40 |
| Net Profit/Loss For the Period | 470.60 | 789.80 | 1700.80 | 1405.20 | 450.40 |
| | | | | | |
| Equity Share Capital | 100.60 | 100.60 | 100.60 | 100.60 | 101.20 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.68 | 7.85 | 16.90 | 13.89 | 4.45 |
| Diluted EPS (Rs.) | 4.68 | 7.85 | 16.90 | 13.89 | 4.45 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.68 | 7.85 | 16.90 | 13.89 | 4.45 |
| Diluted EPS (Rs.) | 4.68 | 7.85 | 16.90 | 13.89 | 4.45 |
| | | | | | |
| PBITOE Margin (%) | 20.54 | 30.85 | 53.89 | 43.17 | 24.09 |
| PBTE Margin (%) | 19.76 | 39.65 | 53.68 | 50.81 | 24.21 |
| PBT Margin (%) | 19.76 | 39.65 | 53.68 | 50.56 | 24.21 |
| PAT Margin (%) | 18.70 | 30.13 | 40.88 | 42.16 | 18.99 |